Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic polymorphisms in the metabolic pathway and non-Hodgkin lymphoma survival.

American journal of hematology - 1 Jan 2010

Han Xuesong, Zheng Tongzhang, Foss Francine M, Lan Qing, Holford Theodore R, Rothman Nathaniel, Ma Shuangge, Zhang Yawei

Abstract excerpt

Metabolic pathway enzymes, such as Cytochrome P450 (CYP), glutathione S-transferase (GST), and N-acetyltransferases (NAT) are involved in activation and detoxification of environmental carcinogens as well as drug metabolism. We hypothesized that the genetic variations in such metabolic pathways may affect NHL prognosis and survival. Follow-up information of 496 female NHL incident cases diagnosed during 1996-2000...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arylamine N-Acetyltransferase
Share to Cytochrome P-450 CYP2E1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glutathione S-Transferase pi

Share to Kaplan-Meier Estimate

Share to Leukemia, Lymphocytic, Chronic, B-Cell

Share to Lymphoma, Follicular

Share to Proportional Hazards Models

Share to Registries

Source

Open in PubMed Open full text

Identifiers

PMID: 20029944
DOI: 10.1002/ajh.21580
PMCID: PMC2964927

Genes

GSTP1
GSTT1
NAT1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic polymorphisms in the metabolic pathway and non-Hodgkin lymphoma survival.PMID 20029944Read ↗

Metabolic gene variants and risk of non-Hodgkin's lymphoma.Semantic proximity Read ↗

Polymorphisms of drug-metabolizing genes and risk of non-Hodgkin lymphoma.Semantic proximity Read ↗

The Impact of Drug Metabolism Gene Polymorphisms on Therapeutic Response and Survival in Diffuse Large B-Cell Lymphoma Patients.Semantic proximity Read ↗

Genetic variation in metabolic genes, occupational solvent exposure, and risk of non-hodgkin lymphoma.Semantic proximity Read ↗

Genetic variation in N-acetyltransferases 1 and 2, cigarette smoking, and risk of non-Hodgkin lymphoma.Semantic proximity Read ↗

Association of NAT and GST polymorphisms with non-Hodgkin's lymphoma: a population-based case-control study.Semantic proximity Read ↗

Role of polymorphisms of GSTM1, GSTT1 and GSTP1 Ile105Val in Hodgkin and non-Hodgkin lymphoma risk: a Human Genome Epidemiology (HuGE) review.Semantic proximity Read ↗

Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma.Semantic proximity Read ↗

Association between xenobiotic gene polymorphisms and non-Hodgkin's lymphoma risk.Semantic proximity Read ↗

Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosisSemantic proximity Read ↗

Vegetables- and antioxidant-related nutrients, genetic susceptibility, and non-Hodgkin lymphoma risk.Semantic proximity Read ↗

Role of genetic factors in development and progression of non-Hodgkin's lymphomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.